Timber Hill’s Myriad Genetics MYGN Stock Holding History

Timber Hill’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,600	Closed	-$300K	–	2341
2016 Q3	$300K	Sell	14,600 -4,900	-25%	-$124K	﹤0.01%	1705
2016 Q2	$597K	Sell	19,500 -10,900	-36%	-$379K	﹤0.01%	1494
2016 Q1	$1.14M	Buy	30,400 +12,300	+68%	+$463K	0.01%	1196
2015 Q4	$781K	Sell	18,100 -20,500	-53%	-$866K	﹤0.01%	1469
2015 Q3	$1.45M	Buy	38,600 +17,700	+85%	+$628K	0.01%	1196
2015 Q2	$710K	Buy	20,900 +11,800	+130%	+$401K	﹤0.01%	1711
2015 Q1	$322K	Buy	+9,100	New	+$326K	﹤0.01%	2008
2013 Q4	–	Sell	-60,900	Closed	-$1.43M	–	3120
2013 Q3	$1.43M	Sell	60,900 -62,900	-51%	-$1.79M	0.01%	1695
2013 Q2	$3.33M	Buy	+123,800	New	+$3.59M	0.01%	1072

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Timber Hill's MYGN Position: Q1 2015 in Review

Timber Hill sold out of Myriad Genetics (MYGN) in Q1 2015, closing a stake of 8,037 shares — an estimated $288K sold.

Timber Hill first reported a position in MYGN in Q4 2014 and held it in 1 quarter. The position peaked at $274K in Q4 2014. 251 funds tracked by Wall St. Rank hold MYGN as of Q1 2015.

Timber Hill reported no remaining Myriad Genetics position as of Q1 2015 after selling out during the quarter.
Timber Hill sold 8,037 Myriad Genetics shares in Q1 2015, an estimated $288K.
Timber Hill first reported a position in Myriad Genetics in Q4 2014 and held it in 1 quarter.
Timber Hill's Myriad Genetics position peaked at $274K in Q4 2014.
251 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2015.

Based on Timber Hill's 13F filing for Q1 2015, filed 30 Apr 2015.